# GLP-1 Drugs Linked to Improved Survival After Liver Transplant

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/aasld/123845) · 2026-11-11 · Medicine
Page: https://themorning.science/story/glp-1-drugs-linked-to-improved-survival-after-liver-transplant-f2559bb6987d2e39
Kind: research · Impact: medium

## In brief

- A retrospective three-center cohort study of 2,402 liver transplant patients found that those taking a GLP-1 receptor agonist had a lower risk of death than those not on a GLP-1 drug.
- The findings were reported in MedPage Today's coverage of an AASLD meeting.

## Why it matters

The study links GLP-1 receptor agonist use to better survival after liver transplant, a possible question for transplant clinicians. Because it is retrospective and observational, it can show an association but not prove that the drugs cause the difference.

## Coverage

- [GLP-1 Drugs Linked to Improved Survival After Liver Transplant](https://www.medpagetoday.com/meetingcoverage/aasld/123845) — MedPageToday.com - medical news for physicians, 2026-11-11

Tags: liver transplant, glp-1 drugs, survival, cohort study, metabolic health

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science